PATENT CLAIM ANALYSIS

Application Number: 16068518
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "369000"]

Abstract:
Provided are a novel compound represented by any one of Formulae 1a and 1b and use thereof. Provided are novel thiazolidinedione derivatives represented by any one of Formulae 1a and 1b and pharmaceutical compositions containing the same.

Claim (Index 23):
The pharmaceutical composition of  claim 14 , wherein the pharmaceutical composition for cell regeneration is used to promote cell regeneration in at least one disease selected from a group consisting of corneal injury, cataract, dementia, neurodegenerative disease, interstitial lung disease, chronic obstructive pulmonary disease, emphysema, cirrhosis, cirrhosis, renal failure, periodontal disease, arthritis, necrotizing skin disease, skin aging, and tumor.

Metadata:
- Claim Count in Document: 28.0
- Percentile: 95.0
- Lexical Diversity: 1.625
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['16063542', '16000108', '15548664', '12853800', '15522969']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7745309687804032
- 35 USC 102 Novelty (BERT): 0.5172813461647687
- Combined Prediction Score: 0.7488060065188398
- Mean Citation Score: 255.649162
- Max Citation Score: 263.0502
- Similarity Product: 166.71479619133473

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test